Skip to main content
. 2004 Apr 3;328(7443):794. doi: 10.1136/bmj.328.7443.794

Table 2.

Details of studies included in systematic review with prevalence estimates of anxiety and depressive disorders

Study Study type No of participants (sexes), age range (years) Outcome measures Prevalence (95% CI)
Rural setting
Population based sample:
Hussain et al 2000w7 Prospective two stage survey 259 (both), ≥18 PHQ cut-off >5, SRQ >8, PAS ID level >4, LEDS AP of A+D=44.4% (35.3 to 53.6). P=57.5% (women), 25.5% (men)
Mumford et al 1996w13 Prospective two stage survey 515 (both), ≥18 BSI-21 cut-off >20, ICD 10R PP of A+D (using BSI-21)=15% (men), 46% (women)
Mumford et al 1997w14 Prospective two stage survey 664 (both), ≥18 BSI-44 cut-off >25, SRQ cut-off >5, ICD 10R, SESP PP of A+D (using BSI-44 and SRQ (high and middle) scores)=25% (men), 66% (women); (using BSI-44)=23% (men), 61% (women); (using SRQ)=26% (men), 75% (women)
Patients of traditional or faith healers:
Malik et al 2000w11 Prospective survey 100 (both), 0-80 ICD 10 D=18%, GAD=5%. (Men: D=6.3%, GAD=4.2%. Women: D=28.8%, GAD=5.8%)
Saeed et al 2000w19 Prospective cross sectional survey 113 (both), No data GHQ 12 cut-off >1, psychiatric interview P of D=12.39%, P of A=1.76%. (Men: D=2.65%, A=0%. Women: D=9.73%%, A=1.76%)
Saeed et al 2000w20 Prospective two stage survey 298 (both), No data GHQ-12 cut-off >1, PAS D=24% (19 to 29), GAD=15% (11 to 19), PA=4% (2 to 7). Men: D=15% (8 to 22), GAD=6% (2 to 12), PA=6% (2 to 12). Women: D=29% (23 to 36), GAD=20% (14 to 25), PA=3% (1 to 7)
Primary care sample:
Dodani et al 2000w4 Prospective cross sectional survey 120 (women), 16-60 Questionnaire, HADS cut-off >10 P of A+D=50%, D=8.3%, A=25%, DA=16.7%.
Urban setting
Population based sample:
Javed 1994w9 Prospective cross sectional survey 200 (both), No data GHQ-30 cut-off >9, HADS cut-off >7 P=33% using GHQ-30, data from HADS unclear.
Mumford et al 2000w15 Prospective two stage survey 760 (both), ≥18 BSI-44 cut-off >20, ICD10 R PP of A+D (using BSI-44)=10% (men), 25% (women)
Rabbani et al 2000w18 Prospective cross sectional survey 260 (women), 15-49 AKUADS cut-off >19, questionnaire PC of A+D=28.8%.
Primary care sample:
Ali et al 1993w1 Prospective cross sectional survey 167 (both), ≥16 HADS cut-off >10 PP of A+D=38.4% (A=19.2%, D=4.2%, DA=15%)
Ali et al 2000w2 Prospective cross sectional survey 487 (both), 16-65 Point prevalence using DSM III R criteria P of A+D=30.4%. Men: A+D=18% (A=5%, D=5.9%, DA=7.1%). Women: A+D=42.2% (A=14.1%, D=9.6%, DA=18.5%)
Psychiatric outpatients:
Gadit et al 1998w5 Retrospective case note study 700 (both), No data Psychiatric interview D=51.6%, A=5.6%, PD=9.1%.
Gadit 2001w6 Retrospective case note study 1430 (both), 0-90 Psychiatric interview D=51.9%, A=5.9%, PD=0.8
Javed et al 1991w8 Retrospective case note study 300 (both), No data Psychiatric interview D=21-30%, A=5-18%, Ph=1-3%, PD=1-15%.
Psychiatric inpatients:
Malik et al 1999w10 Case register based study 177 (both), 10-90 Psychiatric interview D=12.9%, A=6.2%.
Minhas et al 2001w12 Case register based study 2620 (both), No data Psychiatric interview D=37%

Epidemiological terms: AP=adjusted prevalence, PC=probable cases, PP=point prevalence, P=prevalence.

Disorders: A+D=anxiety and depressive disorders, A=anxiety, D=depression, DA=depression with anxiety, GAD=generalised anxiety disorder, PA=panic disorder (with or without agoraphobia),

Ph=phobias, PD=psychosomatic disorder.

Scales: AKUADS=Aga Khan University anxiety and depression scale, BSI=Bradford somatic inventory, DSM III-R=Diagnostic and Statistical Manual (3rd ed revised), GHQ=general health questionnaire, HADS=hospital anxiety and depression scale, ICD-10-R=International Classification of Diseases Research Criteria (10th ed), PAS=psychiatric assessment schedule, PHQ=personal health questionnaire, LEDS=life events and difficulties schedule, SESP=socioeconomic scales for Pakistan, SRQ=self reporting questionnaire.